Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors
US10806726B2 · kind B2 · utility
3Cited by
79References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 23, 2017 |
| Grant date | Oct 20, 2020 |
| Priority date | — |
| Expiry date | Oct 23, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.